News
Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine
Sanofi announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada. The investment in a new facility will provide additional antigen and filling capacity for Sanofi’s Fluzone® High-Dose...
News
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the initiation of crossover arms in two ongoing clinical trials of NVX-CoV2373, the company's COVID-19 vaccine candidate. Crossover ensures the administration of active vaccine to all...
News
SIRO Clinpharm partners with ACROSS Global Alliance; aims to bridge the gap in the pharmaceutical service provider market
SIRO Clinpharm, a Clinical Research Organisation in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap...
Drug Research
Anixa Biosciences, OntoChem ink pact to proceed to next stage of development of potential anti-viral therapy for Covid-19
Anixa Biosciences, Inc., a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that based on Proof of Concept (POC) animal study results, it will progress to the next stage of development of its...
News
Crystec launch a new R&D centre in Haimen, Jiangsu province, China
Crystec are pleased to announce the opening of a new subsidiary, Nantong Crystec Pharmaceutical R&D Co. Ltd., and research facility, located at Haimen Science and Technology Park in Haimen City, Jiangsu Province, China.
Crystec’s new R&D centre has been established...
Drug Research
Iconovo and ISR develop new covid-19 inhalation vaccine
Inhalation device company Iconovo, which offers complete inhalation products, signed an agreement with immunotherapy company ISR Immune System Regulation. The agreement concerns the development of an inhalation vaccine against Covid-19 in Iconovo’s disposable inhaler ICOone. The parties see significant...
News
Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that based on submitted stability data, the U.S. FDA has authorized the Moderna COVID-19 Vaccine to be kept at room temperature conditions once removed from the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read